Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Hemodialysis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Segment
5.4.1 Market Breakup by Product
5.4.2 Market Breakup by Service
5.5 Market Breakup by Modality
5.6 Market Breakup by End-User
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Segment
6.1 Hemodialysis Product
6.1.1 Market Trends
6.1.2 Market Breakup by Product
6.1.2.1 Machines
6.1.2.2 Dialyzers
6.1.2.3 Others
6.1.3 Market Forecast
6.2 Hemodialysis Service
6.2.1 Market Trends
6.2.2 Market Breakup by Service
6.2.2.1 In-center Services
6.2.2.2 Home Services
6.2.3 Market Forecast

7 Market Breakup by Modality
7.1 Conventional Hemodialysis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Short Daily Hemodialysis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Nocturnal Hemodialysis
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Independent Dialysis Centres
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region
9.1 Asia Pacific
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 North America
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porter’s Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Baxter International
13.3.2 Asahi Kasei Corporation
13.3.3 B. Barun Melsungen
13.3.4 DaVita
13.3.5 Cantel Medical Corporation
13.3.6 Fresenius Medical Care
13.3.7 Nipro Corporation
13.3.8 Rockwell Medical
13.3.9 Medivators
13.3.10 Toray Medical Company Ltd.
13.3.11 Nikkiso Co. Ltd.
13.3.12 Surni Group
13.3.13 Gambro
13.3.14 Satellite Healthcare Inc.
13.3.15 Renacon Pharma Ltd.